Healthcare Dive's 2027 conference guide spans the industry's business and policy side, listing events such as the Digital Health Summit at CES, the JP Morgan Healthcare Conference, ViVE, HIMSS, and AHIP. The list targets digital health, provider, and payer leaders, with specific dates and locations for each event. BioPharma Dive's guide takes a different angle, focusing on medical meetings where clinical trial results are often presented and describing them as a barometer of biotech and pharma research progress.
Both guides agree that conferences are especially important in 2027. Healthcare Dive cites historic policy changes, a shifting financial environment, and AI as forces that leaders will need to navigate. BioPharma Dive's guide emphasizes that medical meetings often feature important clinical trial results, making them a barometer of research progress. In both cases, conferences are positioned as places to take the industry's pulse and make connections.
The main difference is scope. Healthcare Dive's list is broad, covering hospital executives, nursing leaders, digital health innovators, and insurers. BioPharma Dive's list is narrower, centered on the research calendar and clinical data that can move markets. Readers looking for specific biopharma meetings will need to consult the original BioPharma Dive article, while those seeking a wider industry overview can start with Healthcare Dive's guide.